Who owns MADRIGAL PHARMACEUTICALS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MDGL from SEC Form 13F filings across 415 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 415 institutions disclosed 23.6M shares of MADRIGAL PHARMACEUTICALS, INC. worth $12.66B — about 80.9% of shares outstanding; the largest disclosed holder is BAKER BROS. ADVISORS LP. Source: SEC Form 13F filings, parsed by EvidInvest.
415
13F holders
$12.66B
value, 2026 filers
80.9%
of shares outstanding (23.6M sh)
82
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MDGL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 2.1M | $1.15B | 5.8% | 7.4% | +0.1% |
| 2 | RTW INVESTMENTS, LP | 2.0M | $1.07B | 9.1% | 6.8% | 0.0% |
| 3 | Jupiter Topco LLCNEW | 1.9M | $1.04B | 0.4% | 6.6% | new |
| 4 | Avoro Capital Advisors LLC | 1.8M | $984.4M | 8.8% | 6.3% | +0.8% |
| 5 | PAULSON & CO. INC. | 1.3M | $719.5M | 27.9% | 4.6% | -3.7% |
| 6 | BlackRock, Inc. | 1.2M | $644.8M | 0.0% | 4.1% | -23.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 835,668 | $448.7M | 0.0% | 2.9% | +1.0% |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 825,714 | $443.4M | 0.1% | 2.8% | +18.8% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 781,731 | $419.8M | 0.0% | 2.7% | -7.1% |
| 10 | STATE STREET CORP | 527,057 | $283.0M | 0.0% | 1.8% | -13.5% |
| 11 | CITADEL ADVISORS LLC | 507,233 | $272.4M | 0.0% | 1.7% | +11.8% |
| 12 | UBS Group AG | 401,708 | $215.7M | 0.0% | 1.4% | +241.1% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 374,880 | $201.3M | 0.0% | 1.3% | -17.8% |
| 14 | FMR LLC | 356,201 | $191.3M | 0.0% | 1.2% | -30.4% |
| 15 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 324,123 | $174.0M | 0.5% | 1.1% | -4.8% |
| 16 | Invesco Ltd. | 301,435 | $161.9M | 0.0% | 1% | -8.5% |
| 17 | ARMISTICE CAPITAL, LLC | 288,000 | $154.6M | 1.9% | 1% | +8.9% |
| 18 | LORD, ABBETT & CO. LLC | 281,500 | $151.2M | 0.4% | 1% | +16.0% |
| 19 | GOLDMAN SACHS GROUP INC | 246,280 | $132.2M | 0.0% | 0.8% | -11.2% |
| 20 | Polar Capital Holdings Plc | 244,274 | $131.2M | 0.3% | 0.8% | -15.6% |
| 21 | AMERIPRISE FINANCIAL INC | 231,205 | $124.1M | 0.0% | 0.8% | +135.5% |
| 22 | NORGES BANKNEW | 213,886 | $114.8M | 0.0% | 0.7% | new |
| 23 | Artisan Partners Limited Partnership | 210,205 | $112.9M | 0.2% | 0.7% | +14.5% |
| 24 | Pictet Asset Management Holding SA | 192,896 | $103.5M | 0.1% | 0.7% | +3.0% |
| 25 | JANE STREET GROUP, LLC | 191,541 | $102.8M | 0.0% | 0.7% | +434.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.